Literature DB >> 2990658

The glioblastoma multiforme in Georgia, 1977-1981.

R E McLendon, J S Robinson, D B Chambers, S Grufferman, P C Burger.   

Abstract

To characterize the incidence and mortality of the glioblastoma multiforme as it is seen at the primary care level, a retrospective study was done through the Georgia Tumor Registry on 299 patients with histologically confirmed supratentorial glioblastoma multiforme. Specifically, the age incidence distribution, sex ratio, and the postoperative survivals were studied. The Registry also provided the opportunity to define the relative racial frequencies of this neoplasm in a large biracial population. The mean age of the patients at the time of surgery was 58.6 years and the age group having the highest incidence was 60 to 74 years. The overall ratio of affected males to females was 1.04 to 1. The postoperative survival periods were considerably shorter than those reported from large cooperative clinical trials. The overall postoperative survivals at 12 and 24 months were only 22% and 4%, respectively. Advancing age had a strong negative relationship with the length of survival such that the 50% survival for patients less than 30 years of age was 17 months, for those age 30 to 44 years it was 10.2 months, for those age 45 to 59 it was 5.8 months, and for those older than 60 it was only 2.2 months. The study confirmed previous suggestions that the incidence of the neoplasm is considerably higher in whites. There were 2.3 glioblastomas in whites for every one in blacks. No difference was noted in the length of survival between whites and blacks.

Entities:  

Mesh:

Year:  1985        PMID: 2990658     DOI: 10.1002/1097-0142(19850815)56:4<894::aid-cncr2820560432>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Guidelines for the treatment of newly diagnosed glioblastoma: introduction.

Authors:  Jeffrey J Olson; Timothy Ryken
Journal:  J Neurooncol       Date:  2008-05-23       Impact factor: 4.130

2.  Brain tumor survival: results from the National Cancer Data Base.

Authors:  T S Surawicz; F Davis; S Freels; E R Laws; H R Menck
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

3.  Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program.

Authors:  Brad E Zacharia; Samuel S Bruce; Hannah Goldstein; Hani R Malone; Alfred I Neugut; Jeffrey N Bruce
Journal:  Neuro Oncol       Date:  2012-06-26       Impact factor: 12.300

4.  Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.

Authors:  Maryam Shabihkhani; Donatello Telesca; Masoud Movassaghi; Yalda B Naeini; Kourosh M Naeini; Seyed Amin Hojat; Diviya Gupta; Gregory M Lucey; Michael Ontiveros; Michael W Wang; Lauren S Hanna; Desiree E Sanchez; Sergey Mareninov; Negar Khanlou; Harry V Vinters; Marvin Bergsneider; Phioanh Leia Nghiemphu; Albert Lai; Linda M Liau; Timothy F Cloughesy; William H Yong
Journal:  J Neurooncol       Date:  2017-02-04       Impact factor: 4.130

5.  An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Authors:  Haley Gittleman; Daniel Lim; Michael W Kattan; Arnab Chakravarti; Mark R Gilbert; Andrew B Lassman; Simon S Lo; Mitchell Machtay; Andrew E Sloan; Erik P Sulman; Devin Tian; Michael A Vogelbaum; Tony J C Wang; Marta Penas-Prado; Emad Youssef; Deborah T Blumenthal; Peixin Zhang; Minesh P Mehta; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

6.  Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.

Authors:  Rodney N Wiltshire; James E Herndon; Annie Lloyd; Henry S Friedman; Darell D Bigner; Sandra H Bigner; Roger E McLendon
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

Review 7.  Epidemiologic and molecular prognostic review of glioblastoma.

Authors:  Jigisha P Thakkar; Therese A Dolecek; Craig Horbinski; Quinn T Ostrom; Donita D Lightner; Jill S Barnholtz-Sloan; John L Villano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-22       Impact factor: 4.254

Review 8.  Racial, ethnic and socioeconomic disparities in the treatment of brain tumors.

Authors:  William T Curry; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

9.  Pediatric neuro-oncology survival disparities in California.

Authors:  Tabitha Cooney; Paul G Fisher; Li Tao; Christina A Clarke; Sonia Partap
Journal:  J Neurooncol       Date:  2018-02-07       Impact factor: 4.130

10.  The future role of personalized medicine in the treatment of glioblastoma multiforme.

Authors:  Jing Li; Chunhui Di; Austin K Mattox; Linda Wu; D Cory Adamson
Journal:  Pharmgenomics Pers Med       Date:  2010-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.